At myTomorrows, we believe everyone should be able to access the treatment options which are open to them. We strive to make it easier for physicians and their patients with unmet medical needs to find, get information about, and access pre-approval medicines whenever possible.
We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world.
To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.
We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world.
To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.
Location: Netherlands
Employees: 51-200
Total raised: $47.63M
Founded date: 2012
Investors 4
| Date | Name | Website |
| - | Octopus Ve... | octopusven... |
| 16.11.2025 | Avego | avego.com |
| - | EQT Ventur... | eqtventure... |
| - | Balderton ... | balderton.... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 11.11.2025 | - | $29.24M | Avego |
| 10.01.2017 | - | $10.59M | Octopus Ve... |
| 07.11.2014 | - | $5.6M | - |
| 19.02.2014 | - | $2.2M | - |
Mentions in press and media 25
| Date | Title | Description |
| 26.05.2026 | b.well Connected Health Partners with myTomorrows to Launch AI-Driven Clinical Trial Matching Stack Beyond the Data Refinery: Why b.well and myTomorrows Are Unifying 2.4M Providers to Match Clinical T... | What You Should Know Consumer health data platform b.well Connected Health has announced a strategic partnership with global health tech leader myTomorrows to automate and accelerate how patients are matched and enrolled into clinical trial... |
| 13.05.2026 | Ditto Raises €7.6 Million To Transform European Healthcare With AI For Patients | Ditto, the Rotterdam-based patient-facing healthcare AI app, has raised €7.6 million to fund its European rollout. The round is led by Heal Capital, with participation from Optiverder and Rubio Impact Ventures. The company won the 2026 Dutc... |
| 12.11.2025 | HealthTech Pioneer myTomorrows Lands $29M to Boost Global Patient Access | myTomorrows, a Dutch HealthTech innovator, just secured a $29 million investment from Avego. This capital injection propels its global mission. The company bridges the critical gap between emerging therapies and patients in need. Its AI-dri... |
| 11.11.2025 | myTomorrows: $29 Million Raised To Expand Global Access To Pre-Approval Therapies | myTomorrows announced it has raised $29 million in new growth funding from Avego to scale its AI-enabled platform that connects patients, physicians, trial sites, and BioPharma partners to pre-approval treatments. The company stated that th... |
| 11.11.2025 | myTomorrows Secures $29M to Fuel Global Expansion of Pre-Approval Therapy Access | What You Should Know: – myTomorrows, a health technology company that connects patients with all possible pre-approval treatments, today announced the close of a $29 million financing with Avego. Avego’s growth equity investment will fuel t... |
| 11.11.2025 | As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million | myTomorrows, a Dutch HealthTech company that connects patients with possible pre-approval treatments, today announced the close of a €25 million financing in order to accelerate the global expansion of its AI-driven platform and enhance acc... |
| 25.02.2025 | Streamlining Clinical Trial Search for UK Patients: myTomorrows and PKB Partnership | What You Should Know: – myTomorrows, a global health technology company connecting patients with all possible pre-approval treatment options, today announced a new partnership with Patients Know Best (PKB), a social enterprise and the leadi... |
| 15.01.2025 | Increasing Participation in Muscular Dystrophy Clinical Trials | Michel van Harten M.D., CEO of myTomorrows Muscular Dystrophy (MD) refers to a group of rare genetic conditions that cause progressive muscle weakness and degeneration in patients. Some forms of MD, such as Duchenne Muscular Dystrophy (DMD)... |
| 27.08.2024 | myTomorrows partners with Pancreatic Cancer Europe to streamline clinical trials | myTomorrows, a global health technology company connecting patients with possible treatment options, twill partner with with Pancreatic Cancer Europe, a multi-stakeholder platform that brings together experts from all over Europe with a com... |
| 22.03.2022 | How a Platform-based, Patient-Centric, Triaging Solution Can Accelerate Clinical Trial Recruitment, Upcoming Webinar Hosted by Xtalks | Patients in need of treatment options increasingly expect a frictionless business-to-consumer experience. TORONTO (PRWEB) March 22, 2022 Clinical trial recruitment is transforming in response to change in the world. Seismic events such as t... |
Show more